In an effort to accelerate disease interception approaches to the management of chronic obstructive pulmonary disease (COPD) and lung cancer, Boston University School of Medicine (BUSM) has entered into a $10.1 million research agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies. Together with the Janssen Disease Interception Accelerator and Oncology […]
In recognition of his major contributions to engineering and to society at large, Professor Selim Ünlü (ECE, BME, MSE) has been selected to receive this year’s Charles DeLisi Award and Lecture. The Charles DeLisi Award and Lecture recognizes faculty members with extraordinary records of well-cited scholarship, senior leaders in industry and extraordinary entrepreneurs who have invented […]
Mark W. Grinstaff of Boston University and Yolonda Colson of Brigham & Women’s Hospital, found that a two-step procedure—delivering a tumor-localizing, drug-absorbing nanoparticle followed by the actual therapeutic—can increase the amount of drug that reaches tumor cells and the amount of time the drug acts on the cells (Scientific Reports 2016, DOI:10.1038/srep18720). Cancer nanomedicine expert […]
Researchers at Boston University School of Medicine (BUSM), under the direction of Sam Thiagalingam, PhD, have identified a new regulatory pathway that may play an important role in basal-like breast cancer (BLBC), a particularly aggressive form of breast cancer often referred to as “triple negative.” This pathway may serve as a target for the development of […]
MED’s Anurag Singh wins grant to study gene in deadly skin cancer. Singh, a MED assistant professor of pharmacology and medicine and XTNC mentor, is tackling this poorly understood melanoma by investigating how NRAS transforms healthy, normal skin cells into aggressive cancerous cells. The work is funded by a three-year, $150,000 grant from the Melanoma […]
Thirty-two hand-picked Boston University researchers convened for a day in September to participate in the Alan Alda Communicating Science Workshop held at BU and led by actors and journalists. The workshop was designed to teach scientists to be tuned-in and persuasive when they communicate their work to lawmakers, federal agencies, and the public…
Darren Roblyer, CNN faculty member and an assistant professor of biomedical engineering, is developing technology to monitor tumors to optimize the treatment selection for patients. Roblyer was awarded a $4 million grant last month from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs to pursue this research.